You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABT-493

Showing 26 - 50 of 384
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AVEIR DR Coverage With Evidence Development (CED) Study

Not yet recruiting
  • Cardiac Pacemaker
  • +2 more
  • Aveir DR Leadless Pacemaker System
  • Dual Chamber Transvenous Pacemaker
  • (no location specified)
Jul 5, 2023

Aveir VR Coverage With Evidence Development Post-Approval Study

Recruiting
  • Cardiac Pacemaker
  • +2 more
  • Aveir VR Leadless Pacemaker System
  • Single-Chamber Transvenous Pacemaker
  • Sylmar, California
    Abbott
Sep 20, 2022

Overweight Trial in United States (RM-493, Placebo)

Completed
  • Overweight
  • Miami, Florida
  • +5 more
Nov 14, 2022

Cardiac Rhythm Disorder, Bradycardia, Cardiac Pacemaker Artificial Trial in United States (Patient Preference Survey)

Recruiting
  • Cardiac Rhythm Disorder
  • +2 more
  • Patient Preference Survey
  • Scottsdale, Arizona
  • +13 more
Sep 9, 2022

Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis

Completed
  • Genetic Obesity
  • +2 more
  • Birmingham, Alabama
  • +57 more
Dec 22, 2022

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Birmingham, Alabama
    A. Brent Carter
Aug 3, 2023

Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)

Suspended
  • Chronic Spontaneous Urticaria
  • ABT Online Programme
  • Delayed Control group
  • Dublin, Ireland
    St James's Hospital
Oct 25, 2023

Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Bowel Trial in Vancouver (Transcutaneous Spinal Cord Stimulation, SHAM

Recruiting
  • Spinal Cord Injuries
  • +2 more
  • Transcutaneous Spinal Cord Stimulation
  • +2 more
  • Vancouver, British Columbia, Canada
    Blusson Spinal Cord Centre
Nov 21, 2022

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Sep 14, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +9 more
Jul 8, 2022

Osteoarthritis of Hip Trial in Oswestry (Bioguard Group, Control Group)

Active, not recruiting
  • Osteoarthritis of Hip
  • Bioguard Group
  • Control Group
  • Oswestry, United Kingdom
    RJAH
Jan 24, 2023

Early-detection Based on Liquid Biopsy in Lymphoid Malignancies

Recruiting
  • Lymphoma
  • early detection test
  • Guangzhou, China
    SunYat-sen university cancer center
Apr 6, 2022

Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, United States (ABT-199, Rituximab)

Completed
  • Small Lymphocytic Lymphoma
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +5 more
Jul 11, 2022

Crohn's Disease (CD) Trial in Worldwide (ABT-494)

Active, not recruiting
  • Crohn's Disease (CD)
  • La Jolla, California
  • +60 more
Sep 8, 2022

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Birmingham, Alabama
  • +41 more
Aug 12, 2019

Syncope, Cryptogenic Stroke Trial in Australia (ConfirmRx (Insertable Cardiac Monitor))

Recruiting
  • Syncope
  • Cryptogenic Stroke
  • ConfirmRx (Insertable Cardiac Monitor)
  • Auchenflower, Queensland, Australia
  • +7 more
Jan 4, 2022

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphoid Leukemia
  • Dresden, Germany
  • +16 more
Nov 8, 2022

Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Lutikizumab
  • Placebo
  • Phoenix, Arizona
  • +54 more
Jan 26, 2023

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))

Not yet recruiting
  • Endometriosis
  • Moderate to Severe Endometriosis-associated Pain
  • BG2109 100mg
  • +5 more
  • (no location specified)
Jun 6, 2023

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021